Garduño-Vieyra L, González-Sánchez CR, Hernández-Da Mota SE, Zavala-Martínez MT

Language: Spanish
References: 19
Page: 556-561
PDF size: 230.39 Kb.

ABSTRACT

Objective: The present study aimed to report the outcomes of patients with progressive keratoconus who were treated via conventional crosslinking (CXL). Method: This retrospective study included 277 eyes of 144 patients with progressive keratoconus who underwent CXL. Topographical measurements were obtained preoperatively and twelve months postoperatively. The best corrected visual acuity (BCVA), flat keratometry (K) value (K1), steep K value (K2), average K value (avgK), K1 axis, K2 axis, pachymetry value and cylindrical value were the studied measures. Results: At the 12-month follow-up, the mean BCVA values were improved. Statistically significant decreases in K1 (p = 0,001), K2 (p = 0.000), K1 axis (p = 0.000), K2 axis (p = 0.004) and avgK (p = 0.025) were observed. The correlation analysis revealed that the preoperative BCVA, K1,K2, K2 axis, avgK and cylinder as well as postoperative K1, K2, avgK and cylinder values significantly affected visual acuity at the 12-month follow-up. Conclusions: CXL was an effective treatment to improve best corrected visual acuity. The preoperative and postoperative K values, preoperative BCVA had a statistically significant correlation with BCVA at 12 months after CXL treatment.

REFERENCES

1. Jeyabalan N, Shetty R, Ghosh A, Anandula VR, Ghosh AS, Kumaramanickavel G. Genetic and genomic perspective to understand the molecular pathogenesis of keratoconus. Indian J Ophthalmol. 2013;61:384-8.

2. Ghanem RC, Santhiago MR, Berti T. Topographic, corneal wavefront, and refractive outcomes 2 years after collagen cross-linking for progressive keratoconus. Cornea. 2014;33:43-8.

3. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Opthalmol. 2006;17:356-60.

4. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen cross-linking for the treatment of keratoconus. Am J Ophthalmol. 2003;135 620-7.

5. Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27:590-4.

6. Greenstein SA, Fry KL, Hersh PS. Corneal topography indices after corneal collagen crosslinking for keratoconus and corneal ectasia: oneyear results. J Cataract Refract Surg. 2011;37:1282-90.

7. Goldich Y, Marcovich AL, Barkana Y, Mandel Y, Hirsh A, Morad Y, et al. Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up. Cornea. 2012;31:609-14.

8. Kanellopoulos AJ. Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results. J Refract Surg. 2009;25:1034-7.

9. McAnena L, O’Keefe M. Corneal collagen crosslinking in children with keratoconus. J AAPOS. 2015;19:228-32.

10. Sedaghat M, Bagheri M, Ghavami S, Bamdad S. Changes in corneal topography and biomechanical properties after collagen cross linking for keratoconus: 1-year results. Middle East Afr J Ophthalmol. 2015; 22:212-9.

11. Hashemi H, Fotouhi A, Miraftab M, Bahrmandy H, Seyedian MA, Amanzadeh K, et al. Short-term comparison of accelerated and standard methods of corneal collagen crosslinking. J Cataract Refract Surg. 2015;41:533-40.

12. Berger Y, Ezra-Nimni O, Skaat A, Fogel M, Grinbaum A, Barequet I. Corneal collagen cross-linking novel technique for prevention of keratoconus progression: results after one-year at the Sheba Medical Center. Harefuah. 2015;154:118-21.

13. Elbaz U, Shen C, Lichtinger A, Zauberman NA, Goldich Y, Chan CC, et al. Accelerated (9-mW/cm2) corneal collagen crosslinking for keratoconus- A 1-year follow-up. Cornea. 2014;33:769-73.

14. Mita M, Waring GO, Tomita M. High-irradiance accelerated collagen crosslinking for the treatment of keratoconus: six-month results. J Cataract Refract Surg. 2014; 40:1032-40.

15. Raiskup F, Theuring A, Pillunat LE, Spoerl E. Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg. 2015;41:41-6.

16. Derakhshan A, Shandiz JH, Ahadi M, Daneshvar R, Esmaily H. Shortterm outcomes of collagen crosslinking for early keratoconus. J Ophthalmic Vis Res. 2011;6:155-9.

17. Toprak I, Yaylalı V, Yildirim C. Factors affecting outcomes of corneal collagen crosslinking treatment. Eye (Lond). 2014;28:41-6.

18. Kirgiz A, Atalay K, Çabuk KŞ, Kaldirim H, Taşkapili M. Factors affecting visual acuity after accelerated crosslinking in patients with progressive keratoconus. Arq Bras Oftalmol. 2016;79:151-4.

19. De Angelis F, Rateau J, Destrieux C, Patat F, Pisella PJ. Predictive factors for visual outcome after corneal collagen crosslinking treatment in progressive keratoconus: one-year refractive and topographic results. J Fr Ophtalmol. 2015;38:595-606.